- +816.2% price growth over the last year
- High gross margin of 89.5%
- Highly efficient cash conversion (100% FCF/OCF ratio)
Evaluation of Verrica Pharmaceuticals Inc stock downgraded after the last trading session
(Updated on Jul 01, 2026)
The Verrica Pharmaceuticals Inc stock price fell by -2.94% on the last day (Wednesday, 1st Jul 2026) from $6.12 to $5.94. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 8.39% from a day low at $5.72 to a day high of $6.20. The price has been going up and down for this period, and there has been a -1% loss for the last 2 weeks. Volume has increased on the last day by 835 shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 35 thousand shares were bought and sold for approximately $209.83 thousand.
The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $5.45 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -3.36% during the next 3 months and, with a 90% probability hold a price between $5.27 and $7.97 at the end of this 3-month period.
VRCA Signals & Forecast
A buy signal was issued from a pivot bottom point on Tuesday, May 19, 2026, and so far it has risen 6.26%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Verrica Pharmaceuticals Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $6.16 and $6.07. A break-up above any of these levels will issue buy signals. Verrica Pharmaceuticals Inc gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".
Support, Risk & Stop-loss for Verrica Pharmaceuticals Inc stock
Verrica Pharmaceuticals Inc finds support from accumulated volume at $5.82 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.480 between high and low, or 8.39%. For the last week, the stock has had daily average volatility of 9.56%.
Our recommended stop-loss: $5.71 (-3.81%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 29 days ago.)
Trading Expectations (VRCA) For The Upcoming Trading Day Of Thursday 2nd
For the upcoming trading day on Thursday, 2nd we expect Verrica Pharmaceuticals Inc to open at $5.95, and during the day (based on 14 day Average True Range), to move between $5.67 and $6.21, which gives a possible trading interval of +/-$0.537 (+/-9.48%) up or down from last closing price. If Verrica Pharmaceuticals Inc takes out the full calculated possible swing range there will be an estimated 9.48% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $5.82 (2.02%) than the resistance at $6.21 (4.55%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Verrica Pharmaceuticals Inc stock A Buy?
Verrica Pharmaceuticals Inc holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.
Current score:
-0.868
Hold/Accumulate
Downgraded
Predicted Fair Opening Price
Predicted fair opening price on July 2, 2026 - $5.95 ( 0.225%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
VRCA Performance
Trading levels for VRCA
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 6.43 | 8.30% |
| R2 | 6.25 | 5.22% |
| R1 | 6.14 | 3.31% |
| Price | 5.94 | |
| S1 | 5.77 | -2.86% |
| S2 | 5.66 | -4.77% |
| S3 | 5.47 | -7.85% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 7.37 | 24.07% |
| R2 | 6.32 | 6.40% |
| R1 | 6.21 | 4.55% |
| Price | 5.94 | |
| S1 | 5.82 | -2.02% |
| S2 | 5.72 | -3.70% |
| S3 | 5.11 | -13.97% |
FAQ
Click here for our free guide on how to buy Verrica Pharmaceuticals Inc Stock.
Buy VRCA